FHA
MRNA icon

Flagship Harbor Advisors’s Moderna MRNA Stock Holding History

Flagship Harbor Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,056
Closed -$31.1K – 1624
2025
Q4 		$31.1K Buy
+1,056
New +$28.7K ﹤0.01% 1200
2024
Q3 		– Sell
-4,106
Closed -$488K – 745
2024
Q2 		$488K Sell
4,106
-218
-5% -$27.6K 0.03% 399
2024
Q1 		$461K Sell
4,324
-88
-2% -$8.87K 0.03% 404
2023
Q4 		$439K Sell
4,412
-125
-3% -$10.5K 0.03% 391
2023
Q3 		$469K Buy
4,537
+526
+13% +$58.7K 0.04% 348
2023
Q2 		$487K Sell
4,011
-4,336
-52% -$578K 0.04% 343
2023
Q1 		$1.28M Buy
8,347
+1,398
+20% +$231K 0.12% 186
2022
Q4 		$1.25M Buy
6,949
+2,412
+53% +$394K 0.13% 185
2022
Q3 		$536K Sell
4,537
-626
-12% -$95K 0.06% 294
2022
Q2 		$737K Buy
5,163
+196
+4% +$28K 0.08% 253
2022
Q1 		$856K Sell
4,967
-328
-6% -$55.2K 0.08% 241
2021
Q4 		$1.34M Sell
5,295
-647
-11% -$189K 0.13% 185
2021
Q3 		$1.4M Hold
5,942
– – 0.15% 157
2021
Q2 		$1.4M Sell
5,942
-2,121
-26% -$379K 0.15% 157
2021
Q1 		$1.06M Buy
8,063
+706
+10% +$102K 0.12% 188
2020
Q4 		$769K Sell
7,357
-2,240
-23% -$227K 0.1% 223
2020
Q3 		$678K Buy
9,597
+2,625
+38% +$183K 0.09% 211
2020
Q2 		$447K Buy
6,972
+1,051
+18% +$57.6K 0.07% 275
2020
Q1 		$177K Buy
5,921
+4,664
+371% +$107K 0.04% 415
2019
Q4 		$25K Buy
1,257
+720
+134% +$12.8K ﹤0.01% 1039
2019
Q3 		$8K Buy
537
+125
+30% +$1.85K ﹤0.01% 1350
2019
Q2 		$6K Hold
412
– – ﹤0.01% 1450
2019
Q1 		$8K Buy
412
+132
+47% +$2.45K ﹤0.01% 1363
2018
Q4 		$4K Buy
+280
New +$4.6K ﹤0.01% 1513

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Flagship Harbor Advisors's MRNA Position: Q1 2026 in Review

Flagship Harbor Advisors sold out of Moderna (MRNA) in Q1 2026, closing a stake of 1,056 shares — an estimated $31.1K sold.

Flagship Harbor Advisors first reported a position in MRNA in Q4 2018 and held it in 24 quarters. The position peaked at $1.4M in Q3 2021. 726 funds tracked by Wall St. Rank hold MRNA as of Q1 2026.

  • Flagship Harbor Advisors reported no remaining Moderna position as of Q1 2026 after selling out during the quarter.
  • Flagship Harbor Advisors sold 1,056 Moderna shares in Q1 2026, an estimated $31.1K.
  • Flagship Harbor Advisors first reported a position in Moderna in Q4 2018 and held it in 24 quarters.
  • Flagship Harbor Advisors's Moderna position peaked at $1.4M in Q3 2021.
  • 726 funds tracked by Wall St. Rank held Moderna as of Q1 2026.

Based on Flagship Harbor Advisors's 13F filing for Q1 2026, filed 28 Apr 2026.